These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23857318)

  • 1. Exploring the chemical space of aromatase inhibitors.
    Nantasenamat C; Li H; Mandi P; Worachartcheewan A; Monnor T; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Mol Divers; 2013 Nov; 17(4):661-77. PubMed ID: 23857318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
    Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
    Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
    Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
    Adhikari N; Baidya SK; Jha T
    Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
    Jiao J; Xiang H; Liao Q
    Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
    Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
    BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of potent aromatase inhibitors by high-throughput docking.
    Caporuscio F; Rastelli G; Imbriano C; Del Rio A
    J Med Chem; 2011 Jun; 54(12):4006-17. PubMed ID: 21604760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.
    Adhikari N; Amin SA; Saha A; Jha T
    Eur J Med Chem; 2017 Sep; 137():365-438. PubMed ID: 28622580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding features of steroidal and nonsteroidal inhibitors.
    Hong Y; Rashid R; Chen S
    Steroids; 2011 Jul; 76(8):802-6. PubMed ID: 21420422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
    Muftuoglu Y; Mustata G
    Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
    Ghosh D; Lo J; Egbuta C
    J Med Chem; 2016 Jun; 59(11):5131-48. PubMed ID: 26689671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
    Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of aromatase inhibitory activity via proteochemometric modeling.
    Simeon S; Spjuth O; Lapins M; Nabu S; Anuwongcharoen N; Prachayasittikul V; Wikberg JE; Nantasenamat C
    PeerJ; 2016; 4():e1979. PubMed ID: 27190705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
    Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
    Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis.
    Muftuoglu Y; Mustata G
    Reprod Biol Endocrinol; 2011 Jun; 9():92. PubMed ID: 21693043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards understanding aromatase inhibitory activity via QSAR modeling.
    Shoombuatong W; Schaduangrat N; Nantasenamat C
    EXCLI J; 2018; 17():688-708. PubMed ID: 30190660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.